Table 1 Clinical characteristics according to type of stroke during follow-up

n

3903

202

145

57

Men (%)

51

63*

63*

61

Age (years)

36.9 ± 11.8

45.8 ± 9.5*

46.6 ± 9.5*

44.4 ± 9.1*

Duration of diabetes (years)

20.0 (11.7–29.3)

31.0 (24.4–36.8)*

32.0 (25.4–37.0)*

28.6 (25.0–34.9)*

Age at stroke (years)

–

52.2 ± 9.8

53.1 ± 10.0

49.9 ± 8.9

Blood pressure measurements

 Systolic blood pressure (mmHg)

133 ± 18

150 ± 23*

150 ± 23*

149 ± 23*

 Diastolic blood pressure (mmHg)

79 ± 10

83 ± 11*

83 ± 11*

83 ± 12*

 Pulse pressure (mmHg)

54 ± 16

67 ± 19*

68 ± 20*

66 ± 18*

 Mean arterial pressure (mmHg)

97 ± 11

105 ± 13

105 ± 13*

105 ± 14*

 Hypertensive (%)

32

66*

68*

60*

 24-h urinary sodium excretion (mmol/l)

140 (101–185)

145 (98–192)

149 (98–202)

138 (96–161)

 24-h urinary potassium excretion (mmol/l)

83 (62–105)

79 (59–104)

79 (56–104)

82 (61–103)

 Sodium/potassium ratio

1.74 (1.32–2.30)

1.76 (1.45–2.33)

1.81 (1.47–2.35)

1.67 (1.39–1.78)

Medication

 Antihypertensive medication (%)

36

78*

78*

77*

  ACE inhibitor (%)

24

45*

48*

38*

  Angiotensin receptor blocker (%)

5

12*

12*

11

  Calcium channel blocker (%)

11

33*

35*

27*

  β-Blocker (%)

12

38*

38*

38*

  Diuretic (%)

11

36*

36*

38*

  Other (%)

1

2*

1

4*